Physician profile
Mustafa I Ahmed
NPI 1306093588
$218,400.24
in general payments reported to CMS, 2019-2025
20 companies · $5,285 in 2025
The $5,285 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $21K · 2021: $23K · 2022: $20K · 2023: $48K · 2024: $68K · 2025: $5,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $53K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Travel and Lodging: $15K · Food and Beverage: $9,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $53,122.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,352.50 |
| Travel and Lodging | $14,714.01 |
| Food and Beverage | $9,421.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $81,934.33 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Abbott Laboratories | $59,817.18 | 2019-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Navitor |
| Boston Scientific Corporation | $23,330.67 | 2019-2024 | Watchman Access System, Versacross Access Solution, Watchman |
| Edwards Lifesciences Corporation | $22,531.48 | 2019-2024 | Sapien 3 Ultra Resilia, Pascal |
| Medtronic Vascular, INC. | $21,200.25 | 2019-2020 | |
| Philips North America LLC | $7,735.77 | 2019-2025 | (8333) Igt D Coronary, Coronary Other, Igt Devices Undivided |
| Abiomed | $588.74 | 2021-2024 | Impella |
| Angiodynamics, INC. | $481.08 | 2022-2025 | Angiovac, Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $236.29 | 2023-2025 | Lifevest |
| Stryker Corporation | $168.50 | 2025 | Venacore Thrombectomy Catheter |
| Penumbra, INC. | $114.59 | 2025 | Indigo System |
| Cardiovascular Systems INC. | $94.21 | 2019 | |
| Chiesi USA, INC. | $44.38 | 2024 | Kengreal |
| Janssen Scientific Affairs, LLC | $42.06 | 2024 | Xarelto |
| Teleflex LLC | $32.68 | 2024 | Manta |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $19.74 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $14.52 | 2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $13.77 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mustafa Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.